164 related articles for article (PubMed ID: 19953611)
1. Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions.
Lin CY; Chen WH; Liao CT; Chen IH; Chiu CC; Wang HM; Yen TC; Lee LY; Chang JT; Cheng AJ
Head Neck; 2010 Aug; 32(8):1028-39. PubMed ID: 19953611
[TBL] [Abstract][Full Text] [Related]
2. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma.
Leonardi R; Pannone G; Magro G; Kudo Y; Takata T; Lo Muzio L
Oncol Rep; 2002; 9(2):261-6. PubMed ID: 11836590
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up.
Montebugnoli L; Cervellati F; Cocchi R; Farnedi A; Pennesi MG; Flamminio F; Foschini MP
Histopathology; 2010 Oct; 57(4):528-34. PubMed ID: 20955378
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
7. Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions.
Liao LJ; Hsu YH; Yu CH; Chiang CP; Jhan JR; Chang LC; Lin JJ; Lou PJ
Head Neck; 2011 May; 33(5):719-26. PubMed ID: 21069851
[TBL] [Abstract][Full Text] [Related]
8. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
9. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
[TBL] [Abstract][Full Text] [Related]
10. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract][Full Text] [Related]
14. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
15. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
16. Oral cancer appearance and management in geriatric patients.
Najjar TA; Gaston GW
Ann Dent; 1980; 39(3):49-55, 64. PubMed ID: 6932182
[No Abstract] [Full Text] [Related]
17. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
[TBL] [Abstract][Full Text] [Related]
18. Tissue expression of gelsolin in oral carcinogenesis progression and its clinicopathological implications.
Shieh DB; Chen IW; Wei TY; Shao CY; Chang HJ; Chung CH; Wong TY; Jin YT
Oral Oncol; 2006 Jul; 42(6):599-606. PubMed ID: 16753328
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
Johnstone S; Logan RM
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic correlations of oral premalignant lesions and squamous cell carcinomas.
Kootman J; El-Mofty SK
J Mo Dent Assoc (1980); 1982; 62(6):33-5. PubMed ID: 6961228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
